Xr Securities LLC Alaunos Therapeutics, Inc. Call Options Transaction History

Xr Securities LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 29, 2021	SELL	$2.82 - $5.6 $72,756 - $144,480	-25,800 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$2.39 - $3.43 $1,434 - $2,058	-600 Reduced 2.27%	25,800 $6,000
Q1 2020 Apr 09, 2020	BUY	$1.9 - $4.98 $2,280 - $5,976	1,200 Added 4.76%	26,400 $17,000
Q4 2019 Jan 06, 2020	SELL	$3.95 - $5.35 $395 - $535	-100 Reduced 0.4%	25,200 $22,000
Q3 2019 Oct 03, 2019	BUY	$4.13 - $6.94 $104,489 - $175,582	25,300 New	25,300 $20,000
Q4 2018 Jan 03, 2019	SELL	$1.61 - $3.62 $19,803 - $44,526	-12,300 Closed	0 $0
Q3 2018 Oct 04, 2018	BUY	$2.26 - $3.27 $27,797 - $40,221	12,300 New	12,300 $3,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.